219 related articles for article (PubMed ID: 6824256)
1. NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases.
Frank MM; Lawley TJ; Hamburger MI; Brown EJ
Ann Intern Med; 1983 Feb; 98(2):206-18. PubMed ID: 6824256
[TBL] [Abstract][Full Text] [Related]
2. Assessment of reticuloendothelial system function in man using receptor-specific probes.
Hamburger MI
Neth J Med; 1984; 27(9):359-67. PubMed ID: 6239984
[No Abstract] [Full Text] [Related]
3. Reticuloendothelial Fc receptor function in patients with Sjogren's syndrome.
O'Sullivan MM; Walker DM; Williams BD
Clin Exp Immunol; 1985 Sep; 61(3):483-8. PubMed ID: 4075586
[TBL] [Abstract][Full Text] [Related]
4. Sjögren's syndrome: a defect in reticuloendothelial system Fc-receptor-specific clearance.
Hamburger MI; Moutsopoulos HM; Lawley TJ; Frank MM
Ann Intern Med; 1979 Oct; 91(4):534-8. PubMed ID: 484951
[TBL] [Abstract][Full Text] [Related]
5. Immune complexes and reticuloendothelial system function in human disease.
Lawley TJ
J Invest Dermatol; 1980 May; 74(5):339-43. PubMed ID: 7391607
[TBL] [Abstract][Full Text] [Related]
6. Reticuloendothelial Fc receptor function in SLE patients. I. Primary HLA linked defect or acquired dysfunction secondary to disease activity?
van der Woude FJ; van der Giessen M; Kallenberg CG; Ouwehand W; Beekhuis H; Beelen JM; van Son WJ; Hoedemaeker PJ; van der Hem GK; The TH
Clin Exp Immunol; 1984 Mar; 55(3):473-80. PubMed ID: 6584255
[TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndrome (Sicca syndrome): current issues.
Moutsopoulos HM; Chused TM; Mann DL; Klippel JH; Fauci AS; Frank MM; Lawley TJ; Hamburger MI
Ann Intern Med; 1980 Feb; 92(2 Pt 1):212-26. PubMed ID: 7352730
[TBL] [Abstract][Full Text] [Related]
8. A serial study of splenic reticuloendothelial system Fc receptor functional activity in systemic lupus erythematosus.
Hamburger MI; Lawley TJ; Kimberly RP; Plotz PH; Frank MM
Arthritis Rheum; 1982 Jan; 25(1):48-54. PubMed ID: 6978134
[TBL] [Abstract][Full Text] [Related]
9. Defective Fc-receptor functions associated with the HLA-B8/DRw3 haplotype: studies in patients with dermatitis herpetiformis and normal subjects.
Lawley TJ; Hall RP; Fauci AS; Katz SI; Hamburger MI; Frank MM
N Engl J Med; 1981 Jan; 304(4):185-92. PubMed ID: 6969363
[TBL] [Abstract][Full Text] [Related]
10. Monocyte receptors for the Fc portion of IgG studies with monomeric human IgG1: normal in vitro expression of Fc gamma receptors in HLA-B8/Drw3 subjects with defective Fc gamma-mediated in vivo clearance.
Fries LF; Hall RP; Lawley TJ; Crabtree GR; Frank MM
J Immunol; 1982 Sep; 129(3):1041-9. PubMed ID: 6980915
[TBL] [Abstract][Full Text] [Related]
11. Fc-specific reticulo-endothelial clearance in systemic lupus erythematosus and glomerulonephritis.
Bannister KM; Hay J; Clarkson AR; Woodroffe AJ
Am J Kidney Dis; 1984 Jan; 3(4):287-92. PubMed ID: 6229179
[TBL] [Abstract][Full Text] [Related]
12. Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus.
Frank MM; Hamburger MI; Lawley TJ; Kimberly RP; Plotz PH
N Engl J Med; 1979 Mar; 300(10):518-23. PubMed ID: 763252
[TBL] [Abstract][Full Text] [Related]
13. The role of Fc gamma receptors in mononuclear phagocyte system function.
Kimberly RP; Salmon JE; Edberg JC; Gibofsky A
Clin Exp Rheumatol; 1989; 7 Suppl 3():S103-8. PubMed ID: 2532576
[TBL] [Abstract][Full Text] [Related]
14. Defective Fc receptor-mediated function of the mononuclear phagocyte system in lupus nephritis.
Parris TM; Kimberly RP; Inman RD; McDougal JS; Gibofsky A; Christian CL
Ann Intern Med; 1982 Oct; 97(4):526-32. PubMed ID: 6957159
[TBL] [Abstract][Full Text] [Related]
15. Fc-receptor function of the mononuclear phagocyte system in glomerulonephritis secondary to some multisystem diseases.
Roccatello D; Coppo R; Martina G; Rollino C; Basolo B; Frattasio C; Fasano ME; Amoroso A; Picciotto G; Bajardi P
Am J Nephrol; 1987; 7(2):85-92. PubMed ID: 2886049
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of complement-mediated solubilisation of antigen-antibody complexes by serum factor(s) in patients with various connective tissue diseases.
Webb J; Zoma A; Cobb S; Veitch J; Whaley K
Aust N Z J Med; 1986 Aug; 16(4):445-51. PubMed ID: 3492194
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes.
Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ
Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674
[TBL] [Abstract][Full Text] [Related]
18. Circulating immune complexes (CIC) in connective tissue diseases (CTD).
Schrieber L; Maini RN
Neth J Med; 1984; 27(9):327-39. PubMed ID: 6239983
[No Abstract] [Full Text] [Related]
19. Speculations on potential anti-receptor autoimmune diseases.
Blecher M
Ciba Found Symp; 1982; (90):279-300. PubMed ID: 6291883
[TBL] [Abstract][Full Text] [Related]
20. Immunoregulation in Sjögren's syndrome: influence of serum factors on T-cell subpopulations.
Moutsopoulos HM; Fauci AS
J Clin Invest; 1980 Feb; 65(2):519-28. PubMed ID: 6444308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
